Market Cap
€31.27 Billion
EUR as of July 1, 2025
US$36.93 Billion
| Company | Market Cap (USD) |
|---|---|
Novo Nordisk
|
$309.91 B |
Vertex Pharmaceuticals Incorporated
|
$117.36 B |
CSL Limited
|
$95.75 B |
Regeneron Pharmaceuticals, Inc.
|
$59.14 B |
| Marinomed Biotech AG | $58.56 B |
| Company | Market Cap (USD) |
|---|---|
Lilly
|
$699.59 B |
Johnson & Johnson
|
$374.29 B |
AbbVie
|
$336.94 B |
Novo Nordisk
|
$309.91 B |
UnitedHealth Group
|
$279.90 B |
Top 1-year algo backtest: +327.04%
$10,000 in March 2024 would now be $42,704 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
UCB SA has the following listings and related stock indices.
Stock: Euronext: UCB
Stock: FSX: UNC
Stock: FSX: UNC0
Stock: OTC: UCBJY
Stock: OTC: UCBJF
The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.